Bioactives of Artemisia dracunculus L. mitigate the role of ceramides in attenuating insulin signaling in rat skeletal muscle cells

Diana N. Obanda, Amy Hernandez, David Ribnicky, Yongmei Yu, Xian H. Zhang, Zhong Q. Wang, William T. Cefalu

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Ectopic lipids in peripheral tissues have been implicated in attenuating insulin action in vivo. The botanical extract of Artemisia dracunculus L. (PMI 5011) improves insulin action, yet the precise mechanism is not known. We sought to determine whether the mechanism by which PMI 5011 improves insulin signaling is through regulation of lipid metabolism. After differentiation, cells were separately preincubated with free fatty acids (FFAs) and ceramide C2, and the effects on glycogen content, insulin signaling, and ceramide profiles were determined. The effect of PMI 5011 on ceramide accumulation and ceramideinduced inhibition of insulin signaling was evaluated. FFAs resulted in increased levels of total ceramides and ceramide species in L6 myotubes. Saturated FFAs and ceramide C2 inhibited insulinstimulated phosphorylation of protein kinase B/Akt and reduced glycogen content. PMI 5011 had no effect on ceramide formation or accumulation but increased insulin sensitivity via restoration of Akt phosphorylation. PMI 5011 also attenuated the FFAinduced upregulation of a negative inhibitor of insulin signaling, i.e., protein tyrosine phosphatase 1B (PTP1B), and increased phosphorylation of PTP1B. PMI 5011 attenuates the reduction in insulin signaling induced by ceramide accumulation, but the mechanism of improved insulin signaling is independent of ceramide formation.

Original languageEnglish (US)
Pages (from-to)597-605
Number of pages9
JournalDiabetes
Volume61
Issue number3
DOIs
StatePublished - Mar 1 2012

Fingerprint

Artemisia
Ceramides
Muscle Cells
Skeletal Muscle
Insulin
Non-Receptor Type 1 Protein Tyrosine Phosphatase
Nonesterified Fatty Acids
Phosphorylation
Glycogen
Proto-Oncogene Proteins c-akt
Skeletal Muscle Fibers
Lipid Metabolism
Insulin Resistance
PMI-5011
Up-Regulation
Fatty Acids
Lipids

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Obanda, Diana N. ; Hernandez, Amy ; Ribnicky, David ; Yu, Yongmei ; Zhang, Xian H. ; Wang, Zhong Q. ; Cefalu, William T. / Bioactives of Artemisia dracunculus L. mitigate the role of ceramides in attenuating insulin signaling in rat skeletal muscle cells. In: Diabetes. 2012 ; Vol. 61, No. 3. pp. 597-605.
@article{11bde5cbf1aa401cbc2658c0e00d9783,
title = "Bioactives of Artemisia dracunculus L. mitigate the role of ceramides in attenuating insulin signaling in rat skeletal muscle cells",
abstract = "Ectopic lipids in peripheral tissues have been implicated in attenuating insulin action in vivo. The botanical extract of Artemisia dracunculus L. (PMI 5011) improves insulin action, yet the precise mechanism is not known. We sought to determine whether the mechanism by which PMI 5011 improves insulin signaling is through regulation of lipid metabolism. After differentiation, cells were separately preincubated with free fatty acids (FFAs) and ceramide C2, and the effects on glycogen content, insulin signaling, and ceramide profiles were determined. The effect of PMI 5011 on ceramide accumulation and ceramideinduced inhibition of insulin signaling was evaluated. FFAs resulted in increased levels of total ceramides and ceramide species in L6 myotubes. Saturated FFAs and ceramide C2 inhibited insulinstimulated phosphorylation of protein kinase B/Akt and reduced glycogen content. PMI 5011 had no effect on ceramide formation or accumulation but increased insulin sensitivity via restoration of Akt phosphorylation. PMI 5011 also attenuated the FFAinduced upregulation of a negative inhibitor of insulin signaling, i.e., protein tyrosine phosphatase 1B (PTP1B), and increased phosphorylation of PTP1B. PMI 5011 attenuates the reduction in insulin signaling induced by ceramide accumulation, but the mechanism of improved insulin signaling is independent of ceramide formation.",
author = "Obanda, {Diana N.} and Amy Hernandez and David Ribnicky and Yongmei Yu and Zhang, {Xian H.} and Wang, {Zhong Q.} and Cefalu, {William T.}",
year = "2012",
month = "3",
day = "1",
doi = "10.2337/db11-0396",
language = "English (US)",
volume = "61",
pages = "597--605",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "3",

}

Bioactives of Artemisia dracunculus L. mitigate the role of ceramides in attenuating insulin signaling in rat skeletal muscle cells. / Obanda, Diana N.; Hernandez, Amy; Ribnicky, David; Yu, Yongmei; Zhang, Xian H.; Wang, Zhong Q.; Cefalu, William T.

In: Diabetes, Vol. 61, No. 3, 01.03.2012, p. 597-605.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Bioactives of Artemisia dracunculus L. mitigate the role of ceramides in attenuating insulin signaling in rat skeletal muscle cells

AU - Obanda, Diana N.

AU - Hernandez, Amy

AU - Ribnicky, David

AU - Yu, Yongmei

AU - Zhang, Xian H.

AU - Wang, Zhong Q.

AU - Cefalu, William T.

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Ectopic lipids in peripheral tissues have been implicated in attenuating insulin action in vivo. The botanical extract of Artemisia dracunculus L. (PMI 5011) improves insulin action, yet the precise mechanism is not known. We sought to determine whether the mechanism by which PMI 5011 improves insulin signaling is through regulation of lipid metabolism. After differentiation, cells were separately preincubated with free fatty acids (FFAs) and ceramide C2, and the effects on glycogen content, insulin signaling, and ceramide profiles were determined. The effect of PMI 5011 on ceramide accumulation and ceramideinduced inhibition of insulin signaling was evaluated. FFAs resulted in increased levels of total ceramides and ceramide species in L6 myotubes. Saturated FFAs and ceramide C2 inhibited insulinstimulated phosphorylation of protein kinase B/Akt and reduced glycogen content. PMI 5011 had no effect on ceramide formation or accumulation but increased insulin sensitivity via restoration of Akt phosphorylation. PMI 5011 also attenuated the FFAinduced upregulation of a negative inhibitor of insulin signaling, i.e., protein tyrosine phosphatase 1B (PTP1B), and increased phosphorylation of PTP1B. PMI 5011 attenuates the reduction in insulin signaling induced by ceramide accumulation, but the mechanism of improved insulin signaling is independent of ceramide formation.

AB - Ectopic lipids in peripheral tissues have been implicated in attenuating insulin action in vivo. The botanical extract of Artemisia dracunculus L. (PMI 5011) improves insulin action, yet the precise mechanism is not known. We sought to determine whether the mechanism by which PMI 5011 improves insulin signaling is through regulation of lipid metabolism. After differentiation, cells were separately preincubated with free fatty acids (FFAs) and ceramide C2, and the effects on glycogen content, insulin signaling, and ceramide profiles were determined. The effect of PMI 5011 on ceramide accumulation and ceramideinduced inhibition of insulin signaling was evaluated. FFAs resulted in increased levels of total ceramides and ceramide species in L6 myotubes. Saturated FFAs and ceramide C2 inhibited insulinstimulated phosphorylation of protein kinase B/Akt and reduced glycogen content. PMI 5011 had no effect on ceramide formation or accumulation but increased insulin sensitivity via restoration of Akt phosphorylation. PMI 5011 also attenuated the FFAinduced upregulation of a negative inhibitor of insulin signaling, i.e., protein tyrosine phosphatase 1B (PTP1B), and increased phosphorylation of PTP1B. PMI 5011 attenuates the reduction in insulin signaling induced by ceramide accumulation, but the mechanism of improved insulin signaling is independent of ceramide formation.

UR - http://www.scopus.com/inward/record.url?scp=84863155142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863155142&partnerID=8YFLogxK

U2 - 10.2337/db11-0396

DO - 10.2337/db11-0396

M3 - Article

C2 - 22315320

AN - SCOPUS:84863155142

VL - 61

SP - 597

EP - 605

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 3

ER -